Table 4.
Outcomes at Six Months by White vs. Black and Hispanic Patients
| N | Unadjusted rates |
Adjusteda
rates |
|||
|---|---|---|---|---|---|
| White n (%) | Black and Hispanic n (%) | White | Black and Hispanic | ||
| Patients, n | 3275 | 2400 | 875 | 2400 | 875 |
| 30 days readmit | 3275 | 670 (27.9) | 270 (30.9) | 27.9 | 30.9 |
| Death | 3275 | 464 (19.3) | 172 (19.7) | 19.2 | 20.0 |
| Hospiceb | 636 | 252 (54.3) | 75 (43.6) | 54.7 | 42.6 |
| Hospice LOS <3 daysb | 636 | 165 (35.6) | 57 (33.1) | 37.0 | 29.7 |
| Chemotherapy | 3275 | 1122 (46.8) | 380 (43.4) | 46.6 | 43.9 |
| Radiation | 3275 | 591 (24.6) | 156 (17.8) | 24.5 | 18.2 |
| Targeted treatment | 3275 | 132 (5.5) | 60 (6.9) | 5.6 | 6.5 |
| ED visit | 3275 | 733 (30.5) | 333 (38.1) | 31.6 | 35.0 |
| Chemotherapy before deathc | 2178 | 573 (35.7) | 189 (33.0) | 35.3 | 34.2 |
| Radiation before deathc | 2178 | 359 (22.4) | 114 (19.9) | 22.0 | 20.8 |
| Targeted chemotherapy before deathc | 2178 | 139 (8.7) | 43 (7.5) | 8.7 | 7.5 |
a
djusted for age, sex, discharge destination, stage at diagnosis, primary payer, and comorbidities.
b
Only among those who died in six-month follow-up.
c
Death at any point, not limited to six-month follow-up period.